Magnetic resonance imaging of myocardial infarction using a manganese-based contrast agent (EVP 1001-1): Preliminary results in a dog model

Journal of Magnetic Resonance Imaging

Volumn 23, Issue 2, 2006, Pages 228-234

  Storey, Pippa ^a,b,e   Chen, Qun ^c   Li, Wei ^a,b   Seoane, Peter R ^d   Harnish, Phillip P ^d   Fogelson, Laura ^a   Harris, Kathleen R ^b   Prasad, Pottumarthi V ^a,b  

^a Evanston Northwestern Healthcare   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Eagle Vision Pharmaceutical Corporation   (United States)

^e EVANSTON HOSPITAL   (United States)

Author keywords

Infarction; Magnetic resonance imaging; Manganese; MEMRI; Myocardium

Indexed keywords

EVP 1001 1; MANGANESE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; TRIPHENYLTETRAZOLIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTRAST ENHANCEMENT; CORONARY ARTERY LIGATION; DOG; HEART INFARCTION; IMAGE ANALYSIS; IMAGING SYSTEM; LEFT CORONARY ARTERY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ANIMALS; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; DOGS; MAGNETIC RESONANCE IMAGING; MANGANESE; MYOCARDIAL INFARCTION; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; SENSITIVITY AND SPECIFICITY;

EID: 31944443231     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.20500     Document Type: Article

References (20)

1. Atkins HL, Som DVM, Fairchild RG, et al. Myocardial positron tomography with manganese-52m. Radiology 1979;133:769-774.
2. Maynard LS, Cotzias GC. The partition of manganese among organs and intracellular organelles of the rat. J Biol Chem 1955;214:489-495.
3. Brady TJ, Goldman MR, Pykett IL, et al. Proton nuclear magnetic resonance imaging of regionally ischemic canine hearts: effect of paramagnetic proton signal enhancement. Radiology 1982;144:343-347.
4. 2. Acta Radiol 1997;38:700-707.
5. Flacke S, Allen JS, Chia JM, et al. Characterization of viable and nonviable myocardium at MR imaging: comparison of gadolinium-based extracellular and blood pool contrast materials versus manganese-based contrast materials in a rat myocardial infarction model. Radiology 2003;226:731-738.
6. Wolf GL, Baum L. Cardiovascular toxicity and tissue proton T1 response to manganese injection in the dog and rabbit. AJR Am J Roentgenol 1983;141:193-197.
7. Yanaga T, Holland WC. Effect of manganese on transmembrane potential and contractility of atrial muscle. Am J Physiol 1969;217:1280-1286.
8. Federle MP, Chezmar JL, Rubin DL, et al. Safety and efficacy of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. multicenter phase III clinical trials (safety). J Magn Reson Imaging 2000;12:186-197.
9. Elizondo G, Fretz CJ, Stark DD, et al. Preclinical evaluation of MnDPDP: new paramagnetic hepatobiliary contrast agent for MR imaging. Radiology 1991;178:73-78.
10. Bremerich J, Saeed M, Arheden H, Higgins CB, Wendland MF. Normal and infarcted myocardium: differentiation with cellular uptake of manganese at MR imaging in a rat model. Radiology 2000;216:524-530.
11. Harnish P, Seoane P, Vessey A. Manganese compositions and methods for MRI. U.S. patent 5980863; 1999.
12. Storey P, Danias PG, Post M, et al. Preliminary evaluation of EVP 1001-1; a new cardiac-specific MR contrast agent with kinetics suitable for steady-state imaging of the ischemic heart. Invest Radiol 2003;38:642-652.
13. Kang YS, Gore JC. Studies of tissue NMR relaxation enhancement by manganese. Invest Radiol 1984;19:399-407.
14. Yang F, Liu YH, Yang XP, Xu J, Kapke A, Carretero OA. Myocardial infarction and cardiac remodelling in mice. Exp Physiol 2002;87:547-555.
15. Lu L, Zhang JQ, Ramires FJ, Sun Y. Molecular and cellular events at the site of myocardial infarction; from the perspective of rebuilding myocardial tissue. Biochem Biophys Res Commun 2004;320:907-913.
16. Camelliti P, Devlin GP, Matthews KG, Kohl P, Green CR. Spatially and temporally distinct expression of fibroblast connexins after sheep ventricular infarction. Cardiovasc Res 2004;62:415-425.
17. Borg DC, Cotzias GC. Manganese metabolism in man: rapid exchange of Mn56 with tissue as demonstrated by blood clearance and liver uptake. J Clin Invest 1958;37:1269-1278.
18. Hu TC, Bao W, Lenhard SC, et al. Simultaneous assessment of left-ventricular infarction size, function and tissue viability in a murine model of myocardial infarction by cardiac manganese-enhanced magnetic resonance imaging (MEMRI). NMR Biomed 2004;17:620-626.
19. Oshinski JN, Yang Z, Jones JR, et al. Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation 2001;104:2838-2842.
20. Decking UK, Pai VM, Wen H, Balaban RS. Does binding of Gd-DTPA to myocardial tissue contribute to late enhancement in a model of acute myocardial infarction? Magn Reson Med 2003;49:168-171.